Clinical trial Recruiting at 3 sites Interventional Ages 18 to 24

Reducing suicide risk among sexual and gender diverse young adults in Texas

Official title: Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care: CRT

Run by University of Kentucky · NCT05869552 · Data updated 2026-11-12

This study is testing two different suicide prevention programs to see which one helps young adults aged 18-24 from sexual and gender diverse backgrounds in Texas feel safer and reduce their risk of suicide.

More Suicide trials

Quick facts

Study typeInterventional
Ages18 Years to 24 Years
SexAll
Enrollment1485 (estimated)
SponsorUniversity of Kentucky
Academic / other
Locations3 sites (Pittsburgh, Pennsylvania and 2 other locations)
StatusRecruiting
StartedJuly 13, 2023
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedNovember 6, 2025
Trial IDNCT05869552 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking individuals aged 18-24 who screen positive for suicide risk and have not received mental health services in the past 90 days.

Probably not a fit

Patients who are actively suicidal, have developmental disabilities, or are impaired due to psychosis, mania, or substance use may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to decrease suicide rates among sexual and gender diverse youth aged 18-24 by comparing two brief suicide prevention interventions tailored for this population. The interventions will be delivered in primary care settings via telehealth, with clinics randomly assigned to one of the two approaches. Participants will be recruited from primary care clinics in metropolitan areas of Texas and will be screened for suicide risk prior to enrollment.

Why it matters

Potential benefit: If successful, this study could significantly lower suicide rates among sexual and gender diverse young adults.

How similar studies have gone: Other studies have shown promise in using tailored interventions for suicide prevention among diverse populations, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* be aged 18-24 at the time of enrollment
* not have received mental health services in the past 90 days, excluding medication and case management
* English-speaking
* screen positive for suicide risk

Exclusion Criteria:

* are actively suicidal
* have a developmental disability that would preclude them from participating in the study intervention
* who are impaired due to psychosis, mania, or substance use that would prevent them from providing consent.
* Participants will also be excluded at YST-III sites if they are unable to identify a minimum of one support person to participate in the intervention with them

Where it's running

  • University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Steve Hicks School of Social Work at the University of Texas at Austin
    Austin, Texas, United States
    Recruiting
  • University of Texas Southwestern Medical Center
    Dallas, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Elizabeth Arnold, PhD — University of Kentucky
  • Study coordinator: Elizabeth Arnold, PhD
  • Email: Liz.Arnold@uky.edu
  • Phone: 859-562-3751

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.